Pyxis Oncology Successfully Completes Acquisition of Apexigen
Go back to Pyxis Oncology Successfully Completes Acquisition of Apexigen| (NASDAQ: PYXS) | Delayed: 1.37 +0.02 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.35 | 52 Week High | $ | |||
| Open | $1.36 | 52 Week Low | $ | |||
| Day High | $1.39 | P/E | N/A | |||
| Day Low | $1.33 | EPS | $ | |||
| Volume | 273,556 | |||||
